• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24738 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Haute Autorite de sante (HAS) [Assessment of pulp wound protection by direct pulp capping]
2025     The Danish Health Technology Council (DHTC) [Assessment of point-of-care tests for use at home for elderly patients]
2023     The Danish Health Technology Council (DHTC) [Assessment of pocket-sized handheld ultrasound devices for point-of-care examination of patients in emergency departments]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Assessment of Perinatal Outcome after Sustained Tocolysis for Early Labour (APOSTEL II)]
2025     The Danish Health Technology Council (DHTC) [Assessment of percutaneous vertebroplasty (PVP) for compression fractures]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of pelvic floor training during pregnancy for the prevention of pre and postnatal urinary incontinence]
2024     The Danish Health Technology Council (DHTC) [Assessment of non-surgical treatment of distal radius fractures in patients older than 65 years]
2014     Haute Autorite de sante (HAS) [Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients]
2025     The Danish Health Technology Council (DHTC) [Assessment of Merlin Assay for diagnosis of malignant melanoma]
2010     Haute Autorite de sante (HAS) [Assessment of medical devices for home infusion]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of lung cancer screening using low-dose computed tomography]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of healthcare status and therapeutic recommendations concerning attention deficit hyperactivity disorder]
2025     The Danish Health Technology Council (DHTC) [Assessment of HAL-assisted TUR-BT]
2011     Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2025     The Danish Health Technology Council (DHTC) [Assessment of forearm fractures in children]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of factors related to the pharmaceutical expenditure in Primary Care, and prescription quality in chronic diseases]
2025     The Danish Health Technology Council (DHTC) [Assessment of endovascular aortic repair (EVAR)]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of effectiveness and safety of Cyberknife and Gamma knife radiosurgery in intra and extracraneal lesions' treatment (update)]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical cancer]
2025     Haute Autorite de sante (HAS) [Assessment of drug-induced sleep endoscopy (DISE) in adults with obstructive sleep apnoea (OSA)]
2009     Haute Autorite de sante (HAS) [Assessment of drug-eluting stents]
2024     The Danish Health Technology Council (DHTC) [Assessment of domiciliary non-invasive ventilation for patients with chronic obstructive pulmonary disease]
2015     Haute Autorite de sante (HAS) [Assessment of diagnostic and therapeutic parotid and submandibular sialendoscopy]
2015     Haute Autorite de sante (HAS) [Assessment of cardiovascular magnetic resonance compared to coronography and computed tomography]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of cardiac magnetic resonance imaging in coronary heart disease]
2009     Haute Autorite de sante (HAS) [Assessment of breast implants, tissue expanders and external breast prostheses]
2024     Canary Health Service [Assessment of body composition using electrical bioimpedance for the evaluation of overweight and obesity in primary care]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment of bilateral cochlear implants in children. Indication criteria for cochlear implants in children and adults]
2012     Haute Autorite de sante (HAS) [Assessment of an epiretinal prosthesis and its implantation procedure]
1999     Finnish Office for Health Care Technology Assessment (Finohta) [Assessment of an electronic referral and teleconsultation system between secondary and primary health care]
2015     Haute Autorite de sante (HAS) [Assessment of an edge-to-edge mitral valve repair clip and its implantation]
2023     The Danish Health Technology Council (DHTC) [Assessment concerning glucose monitoring for the treatment of adult patients with type 1 diabetes]
2019     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Assessment and interventions in care and services for older adults - an evidence map]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Assessment and clinical management of self-harm in adolescence: evidence-based protocol]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment and analysis of studies on rare diseases - Rapid report]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Assesment of artificial intelligence´s diagnostic yield and security in cardiac monitoring using insertable cardiac monitors]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Aspirin prescription pattern among diabetic patients for prevention of cardiovascular disease]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asfotase alfa: assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asfotase alfa (hypophosphatasia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asfotase alfa (hypophosphatasia) - Addendum to Commission A19-89]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asciminib (chronic myeloid leukaemia) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asciminib (chronic myeloid leukaemia) – Addendum to Project A25-70]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asciminib (chronic myeloid leukaemia) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Artificial urinary sphincter post-prostatectomy]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Artificial urinary sphincter in pediatric patients]
2022     Canary Health Service [Artificial pancreas with dual release of insulin and pramlintide for treatment of type 1 diabetes mellitus]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Artificial liver support systems]
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Artificial intelligence-based screening test for emergent large vessel occlusion using non-contrast brain CT images]
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Artificial intelligence-based diagnostic assistant test for paroxysmal atrial fibrillation using 12-lead electrocardiogram data]
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Artificial intelligence-based diagnostic assistant test for acute myocardial infarction using 12-lead electrocardiogram data]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Artificial intelligence software to detect viable tissue in stroke patients on CT or perfusion MRI of the skull]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Artificial intelligence in medical imaging: fields of application and considerations for its deployment in Quebec]
2024     HTA South [Artificial intelligence in breast cancer screening with mammography]
2023     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Artificial intelligence for the detection of colorectal precancerous lesions in colonoscopy]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Artificial disc replacement]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Arthroscopy with joint washout in the treatment of knee arthrosis]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Arthroscopy of the knee joint for gonarthrosis]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Arthroplasty register for Germany]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Arthroplasty register for Germany]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Arthrofibrosis (excessive scarring) in the knee: can surgical procedures reduce movement restrictions and pain?]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Arterial stiffness measurement for cardiovascular risk classification in high blood pressure patients]
2024     Agency of Health Technology Assessment of Uruguay (AETSU) [Arsenic trioxide for the treatment of acute promyelocytic leukemia]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Arrhythmia ablation by EnSite NavX electroanatomical mapping]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Aromatase inhibitors in female breast cancer]
2014     The Swedish Council on Health Technology Assessment (SBU) [Aromatase inhibitors for early-stage breast cancer]
2017     Canary Health Service [Argus II. Retinal Prosthesis System]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Argon plasma coagulation for gastrointestinal lesions]
2015     The Swedish Council on Health Technology Assessment (SBU) [Arginine and caries prevention]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [AR101 (Peanut allergy) - Benefit assessment according to §35a Social Code Book V]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [AR101 (peanut allergy) - Addendum to Commission A21-135]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [AR101 (peanut allergy, 1 to 3 years) – Benefit assessment according to §35a Social Code Book V]
2015     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Aquapheresis – ultrafiltartion for congestive heart failure]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apremilast (plaque psoriasis) – Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apremilast (Behçet’s disease) - Benefit assessment according to §35a Social Code Book V]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apremilast - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Systematic review of the admission criteria in acute decompensated heart failure]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Efficacy and safety of pharmacological treatment for bipolar disorder]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Development of explicit criteria for indication of admission in COPD exacerbation]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Development of appropriateness explicit criteria for carotid revascularization]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies : appropriate admission explicit criteria for heart failure (HF)]
2009     Canary Health Service [Appropriateness in the indication of physical therapy techniques for cervical pain, low back pain and chronic shoulder pain of non-specific origin]
2009     Andalusian Health Technology Assessment Area (AETSA) [Appropriateness criteria for vertebral arthrodesis]
2009     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of recombinant activated factor VII in nonhaemophilic patients]
2026     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of laboratory tests – (1-3)-β-D-glucan serum testing]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of laboratory tests - direct bilirubin testing]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of laboratory tests - bleeding time (in vivo)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of laboratory tests - aspartate aminotransferase testing in the investigation of liver injury]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of laboratory tests - 25-OH vitamin D testing]
2000     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of Factor VIII in the treatment of haemophilia. A Literature review and opinions of an expert panel on the correct use of different preparations of Factor VIII]
2005     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of Factor VIII for treatment of hemophilia - A consensus conference]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in primary and secondary care : ultrasonography in breast pathology]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in acute abdominal pain]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of cardiac monitoring in the emergency department]
2023     Andalusian Health Technology Assessment Area (AETSA) [Appropiate indication for leadless pacemaker. Systematic review and appropriateness criteria]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Approach to personality disorders in the mental health system of the Basque Country]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Appraisal of the variability and suitability of prescribing antimicrobials in primary health care in the Basque Country]
2026     Institut national d'excellence en sante et en services sociaux (INESSS) [Application of the INESSS framework : assessing the value of digital technologies in health and social services]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011     Andalusian Health Technology Assessment Area (AETSA) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Applicability of sentinel-lymph-node detection and biopsy in the treatment of vulval cancer]